Trademark: 86024885
Word
AVIVENT
Status
Dead
Status Code
606
Status Date
Monday, September 14, 2015
Serial Number
86024885
Mark Type
4000
Filing Date
Wednesday, July 31, 2013
Published for Opposition
Tuesday, December 17, 2013
Abandoned Date
Monday, September 14, 2015

Trademark Owner History
Glaxo Group Limited - Owner At Publication

Classifications
5 Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
The wording "AVIVENT" has no meaning in a foreign language.

Trademark Events
Sep 14, 2015
Abandonment Notice Mailed - No Use Statement Filed
Sep 14, 2015
Abandonment - No Use Statement Filed
Jun 22, 2015
Teas Change Of Correspondence Received
Mar 3, 2015
Notice Of Approval Of Extension Request E-Mailed
Feb 28, 2015
Extension 2 Granted
Jan 15, 2015
Extension 2 Filed
Feb 28, 2015
Case Assigned To Intent To Use Paralegal
Jan 15, 2015
Teas Extension Received
Jul 16, 2014
Notice Of Approval Of Extension Request E-Mailed
Jul 14, 2014
Extension 1 Granted
Jul 14, 2014
Extension 1 Filed
Jul 14, 2014
Teas Extension Received
Feb 11, 2014
Noa E-Mailed - Sou Required From Applicant
Dec 17, 2013
Official Gazette Publication Confirmation E-Mailed
Dec 17, 2013
Published For Opposition
Nov 27, 2013
Notification Of Notice Of Publication E-Mailed
Nov 12, 2013
Approved For Pub - Principal Register
Nov 8, 2013
Assigned To Examiner
Aug 7, 2013
New Application Office Supplied Data Entered In Tram
Aug 3, 2013
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24